Characteristics and Outcomes Among Adults Aged [greater than or equal to] 60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus--RSV-NET, 12 States, July 2022-June 2023

Authors :: Havers, Fiona P.
Whitaker, Michael
Melgar, Michael
Chatwani, Bhoomija
Chai, Shua J.
Alden, Nisha B.
Meek, James
Openo, Kyle P.
Ryan, Patricia A.
Kim, Sue
Lynfield, Ruth
Shaw, Yomei P.
Barney, Grant
Tesini, Brenda L.
Sutton, Melissa
Talbot, H. Keipp
Olsen, Kristen P.
Patton, Monica E.
Source :: Morbidity and Mortality Weekly Report. October 6, 2023, Vol. 72 Issue 40, p1075, 8 p.
Publication Year :: 2023
Abstract: Introduction Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in older adults, resulting in approximately 60,000-160,000 hospitalizations and 6,000-10,000 deaths annually among adults aged [greater than or equal to] [...]

Subjects :: Vaccination
Lung diseases -- Patient outcomes
Mortality
Medical colleges
Long-term care of the sick
Adults
Vaccines
Health

Tools